Valuation CSPC Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. 09:08:16 16/10/2026 BST			5-day change	1st Jan Change
8.880 ^HKD	+0.17%		-2.26%	+5.34%

10-15	CSPC Pharma Gets China Nod for Tumor Drug Trial	MT
10-15	CSPC Pharmaceutical Group Limited Obtains Clinical Trial Approval For SYS6088 Injection In China	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	100,932	97,707	86,022	55,169	96,380	101,374	-	-
Change	-	-3.19%	-11.96%	-35.87%	74.7%	5.18%	-	-
Enterprise Value (EV) ¹	89,633	86,241	72,284	46,931	86,710	90,157	87,089	83,948
Change	-	-3.79%	-16.18%	-35.07%	84.76%	3.98%	-3.4%	-3.61%
P/E	14.7x	14.1x	13.5x	12.1x	21.8x	10x	14.7x	13.8x
PBR	3.17x	2.86x	2.39x	1.62x	2.56x	2.26x	2.11x	1.96x
PEG	-	14.13x	-1.73x	-0.5x	-9.88x	0x	-0.5x	2.08x
Capitalization / Revenue	2.94x	2.77x	2.52x	1.78x	3.26x	2.63x	2.84x	2.68x
EV / Revenue	2.61x	2.44x	2.12x	1.51x	2.94x	2.34x	2.44x	2.22x
EV / EBITDA	9.5x	9.43x	8.39x	6.22x	12.1x	6.57x	9.09x	7.86x
EV / EBIT	10.7x	10.8x	9.77x	7.68x	15.6x	7.4x	10.8x	9.91x
EV / FCF	23.7x	14.1x	26.2x	17.5x	19.5x	11.8x	13.1x	12.2x
FCF Yield	4.22%	7.11%	3.82%	5.71%	5.12%	8.47%	7.63%	8.23%
Dividend per Share ²	0.18	0.21	0.28	0.26	0.29	0.4599	0.3684	0.3916
Rate of return	2.13%	2.56%	3.86%	5.44%	3.44%	5.18%	4.15%	4.41%
EPS ²	0.5773	0.5831	0.5376	0.3946	0.3859	0.8884	0.6024	0.6424
Distribution rate	31.2%	36%	52.1%	65.9%	75.2%	51.8%	61.1%	61%
Net sales ¹	34,309	35,292	34,175	31,046	29,533	38,479	35,690	37,822
EBITDA ¹	9,431	9,148	8,615	7,547	7,168	13,726	9,582	10,679
EBIT ¹	8,366	7,952	7,400	6,113	5,564	12,181	8,042	8,470
Net income ¹	6,901	6,949	6,382	4,632	4,409	10,143	7,018	7,510
Net Debt ¹	-11,298	-11,467	-13,738	-8,238	-9,670	-11,217	-14,285	-17,426
Reference price ²	8.470	8.200	7.260	4.780	8.430	8.880	8.880	8.880
Nbr of stocks (in thousands)	11,916,370	11,915,520	11,848,756	11,541,665	11,433,025	11,416,025	-	-
Announcement Date	22/03/22	22/03/23	20/03/24	28/03/25	25/03/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CSPC PHARMACEUTICAL GROUP LIMITED	10x	2.34x	6.57x	5.18%	12.92B
ELI LILLY AND COMPANY	35.96x	12.96x	27.14x	0.55%	1,120B
JOHNSON & JOHNSON	37.4x	6.3x	17.74x	2.09%	616B
ABBVIE INC.	36.43x	8.36x	17.24x	2.43%	504B
ROCHE HOLDING AG	20.46x	4.99x	12.38x	2.64%	367B
MERCK & CO., INC.	106.52x	5.95x	25.12x	2.33%	360B
NOVARTIS AG	21.18x	5.54x	13.63x	2.88%	288B
ASTRAZENECA PLC	21.7x	4.38x	12.55x	2.01%	258B
AMGEN INC.	27.46x	7.06x	12.64x	2.33%	234B
GILEAD SCIENCES, INC.	-45.63x	6.99x	27.07x	2.11%	194B
Average	27.15x	6.49x	17.21x	2.46%	395.38B
Weighted average by Cap.	34.64x	8.18x	19.99x	1.85%